JP2020521838A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020521838A5 JP2020521838A5 JP2019564777A JP2019564777A JP2020521838A5 JP 2020521838 A5 JP2020521838 A5 JP 2020521838A5 JP 2019564777 A JP2019564777 A JP 2019564777A JP 2019564777 A JP2019564777 A JP 2019564777A JP 2020521838 A5 JP2020521838 A5 JP 2020521838A5
- Authority
- JP
- Japan
- Prior art keywords
- polymer fraction
- factor
- infections
- polymer
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920000642 polymer Polymers 0.000 claims description 54
- 238000000034 method Methods 0.000 claims description 32
- 208000015181 infectious disease Diseases 0.000 claims description 29
- 239000000203 mixture Substances 0.000 claims description 15
- 208000035473 Communicable disease Diseases 0.000 claims description 10
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- 206010028980 Neoplasm Diseases 0.000 claims description 6
- 230000001580 bacterial effect Effects 0.000 claims description 6
- 230000002538 fungal effect Effects 0.000 claims description 6
- 208000032376 Lung infection Diseases 0.000 claims description 5
- 230000003612 virological effect Effects 0.000 claims description 5
- UBDZFAGVPPMTIT-UHFFFAOYSA-N 2-aminoguanidine;hydron;chloride Chemical compound [Cl-].NC(N)=N[NH3+] UBDZFAGVPPMTIT-UHFFFAOYSA-N 0.000 claims description 4
- UJTTUOLQLCQZEA-UHFFFAOYSA-N 9h-fluoren-9-ylmethyl n-(4-hydroxybutyl)carbamate Chemical compound C1=CC=C2C(COC(=O)NCCCCO)C3=CC=CC=C3C2=C1 UJTTUOLQLCQZEA-UHFFFAOYSA-N 0.000 claims description 4
- 206010035664 Pneumonia Diseases 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 239000003242 anti bacterial agent Substances 0.000 claims description 4
- 201000011510 cancer Diseases 0.000 claims description 4
- XEVRDFDBXJMZFG-UHFFFAOYSA-N carbonyl dihydrazine Chemical compound NNC(=O)NN XEVRDFDBXJMZFG-UHFFFAOYSA-N 0.000 claims description 4
- 238000000502 dialysis Methods 0.000 claims description 4
- 150000002357 guanidines Chemical class 0.000 claims description 4
- DUIOPKIIICUYRZ-UHFFFAOYSA-N semicarbazide Chemical compound NNC(N)=O DUIOPKIIICUYRZ-UHFFFAOYSA-N 0.000 claims description 4
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 claims description 3
- 206010062255 Soft tissue infection Diseases 0.000 claims description 3
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 claims description 3
- 206010040872 skin infection Diseases 0.000 claims description 3
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims description 2
- 208000001860 Eye Infections Diseases 0.000 claims description 2
- 208000025865 Ulcer Diseases 0.000 claims description 2
- 208000027418 Wounds and injury Diseases 0.000 claims description 2
- 206010000269 abscess Diseases 0.000 claims description 2
- 239000002246 antineoplastic agent Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 claims description 2
- 208000011323 eye infectious disease Diseases 0.000 claims description 2
- 230000002401 inhibitory effect Effects 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 229940124531 pharmaceutical excipient Drugs 0.000 claims description 2
- 230000009885 systemic effect Effects 0.000 claims description 2
- 231100000397 ulcer Toxicity 0.000 claims description 2
- 208000003322 Coinfection Diseases 0.000 claims 2
- 230000002685 pulmonary effect Effects 0.000 claims 2
- 201000003883 Cystic fibrosis Diseases 0.000 claims 1
- 206010065764 Mucosal infection Diseases 0.000 claims 1
- 206010028741 Nasal inflammation Diseases 0.000 claims 1
- 206010052428 Wound Diseases 0.000 claims 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241000222126 [Candida] glabrata Species 0.000 description 1
- 208000032343 candida glabrata infection Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762510446P | 2017-05-24 | 2017-05-24 | |
| US62/510,446 | 2017-05-24 | ||
| US201862633761P | 2018-02-22 | 2018-02-22 | |
| US62/633,761 | 2018-02-22 | ||
| PCT/US2018/033880 WO2018217743A1 (en) | 2017-05-24 | 2018-05-22 | Fractionated antimicrobial compositions and use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020521838A JP2020521838A (ja) | 2020-07-27 |
| JP2020521838A5 true JP2020521838A5 (enExample) | 2021-04-22 |
| JP7475144B2 JP7475144B2 (ja) | 2024-04-26 |
Family
ID=64395893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019564777A Active JP7475144B2 (ja) | 2017-05-24 | 2018-05-22 | 分画抗菌組成物およびその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11285170B2 (enExample) |
| EP (1) | EP3630082A4 (enExample) |
| JP (1) | JP7475144B2 (enExample) |
| CN (1) | CN111093646A (enExample) |
| AU (1) | AU2018272839B2 (enExample) |
| BR (1) | BR112019024628A2 (enExample) |
| CA (1) | CA3064733A1 (enExample) |
| IL (1) | IL270759B2 (enExample) |
| WO (1) | WO2018217743A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022214963A1 (en) * | 2021-04-05 | 2022-10-13 | Victor Tets | Bioactive products |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2039735C1 (ru) | 1993-04-29 | 1995-07-20 | Петр Александрович Гембицкий | Способ получения дезинфицирующего средства |
| WO1996028570A1 (en) | 1995-03-09 | 1996-09-19 | Xechem, Inc. | A rapid method of and diagnostic kit for the detection of microorganisms |
| US6984499B2 (en) | 1997-10-02 | 2006-01-10 | Idexx Laboratories, Inc. | Method and apparatus for concurrently detecting pathogenic organisms and antimicrobial susceptibility |
| RU2141452C1 (ru) | 1998-05-26 | 1999-11-20 | ООО "Торговый дом "Красный химик" | Способ получения кобальт (ii) сульфата |
| RU2176651C2 (ru) | 1999-11-11 | 2001-12-10 | Институт эколого-технологических проблем | Способ получения блоксополимера алкиленгуанидина с полиалкиленамином и блоксополимер |
| US20020010150A1 (en) | 2000-04-28 | 2002-01-24 | Cortese Stephanie M. | Homostatic compositions of polyacids and polyalkylene oxides and methods for their use |
| RU2176523C1 (ru) | 2000-06-16 | 2001-12-10 | Региональная общественная организация - Институт эколого-технологических проблем | Дезинфицирующее средство при туберкулезе |
| RS95404A (sr) | 2002-05-03 | 2006-10-27 | Schering Aktiengesellschaft | Tiazolidinoni i njihova primena kao inhibitora polo like kinaze |
| US8100872B2 (en) | 2002-10-23 | 2012-01-24 | Tyco Healthcare Group Lp | Medical dressing containing antimicrobial agent |
| AU2003291087A1 (en) * | 2002-11-19 | 2004-06-15 | Genzyme Corporation | Ionene oligomers and polymers |
| RU2230734C1 (ru) | 2003-06-09 | 2004-06-20 | Общество с ограниченной ответственностью "Международный институт эколого-технологических проблем" | Производные полигуанидинов |
| JP4629987B2 (ja) * | 2004-03-19 | 2011-02-09 | 日本ペイント株式会社 | シーリング剤、リン酸塩処理鋼板の被覆方法及びリン酸塩処理鋼板 |
| CA2565556A1 (en) * | 2004-05-03 | 2005-12-08 | Neosil, Inc. | Polycationic antimicrobial therapeutic |
| RU2324478C2 (ru) | 2006-06-27 | 2008-05-20 | Общество с ограниченной ответственностью "Международный институт эколого-технологических проблем" | Способ получения биоцидного полигуанидина и биоцидный полигуанидин |
| EP2044083A1 (en) | 2006-07-14 | 2009-04-08 | Genelabs Technologies, Inc. | Antiviral agents |
| RU2422137C1 (ru) | 2009-10-08 | 2011-06-27 | Виктор Вениаминович Тец | Способ получения биоцидного полигуанидина и биоцидный полигуанидин |
| RU2423359C1 (ru) | 2009-12-02 | 2011-07-10 | Федеральное государственное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФГУН ГНЦ ВБ "Вектор" Роспотребнадзора) | Противовирусное средство |
| WO2011135577A1 (en) | 2010-04-29 | 2011-11-03 | Bios Agricorp Pvt. Ltd. | Polyhexamethyleneguanidine and its salts based disinfectant. |
| CN102453315B (zh) * | 2010-10-22 | 2014-05-28 | 中国石油化工股份有限公司 | 一种抗菌防霉聚乳酸组合物及其制备方法 |
| EP2701729B1 (en) | 2011-04-27 | 2019-05-22 | Biom'up | Hemostatic compositions |
| RU2480227C2 (ru) | 2011-07-01 | 2013-04-27 | Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" (ФБУН ГНЦ ВИ "Вектор") | Противовирусное средство на основе меланина |
| JP6195567B2 (ja) | 2011-10-11 | 2017-09-13 | バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ | 止血組成物 |
| US8829053B2 (en) | 2011-12-07 | 2014-09-09 | Rochal Industries Llp | Biocidal compositions and methods of using the same |
| RU2533232C2 (ru) | 2012-07-20 | 2014-11-20 | Федеральное государственное бюджетное учреждение "Научно-исследовательский институт вирусологии им. Д.И. Ивановского" Министерства здравоохранения и социального развития Российской Федерации (ФГБУ "НИИ вирусологии им. Д.И. Ивановского" Минздравсоцразвития России | Применение поликарбоксильного производного фуллерена в качестве микробицидного противовирусного средства |
| US9439433B2 (en) * | 2013-05-22 | 2016-09-13 | Curza Global, Llc | Compositions and methods comprising a biocidal polyamine |
| CN103705535A (zh) | 2013-12-27 | 2014-04-09 | 王东宇 | 壳聚糖妇科凝胶及其制备方法 |
| RU2546006C1 (ru) | 2014-03-07 | 2015-04-10 | Римма Ильинична Ашкинази | Противовирусное средство |
| WO2016118043A1 (ru) | 2015-01-20 | 2016-07-28 | Виктор Вениаминович ТЕЦ | Гемостатическое средство |
-
2018
- 2018-05-22 EP EP18806686.4A patent/EP3630082A4/en active Pending
- 2018-05-22 JP JP2019564777A patent/JP7475144B2/ja active Active
- 2018-05-22 WO PCT/US2018/033880 patent/WO2018217743A1/en not_active Ceased
- 2018-05-22 US US16/616,325 patent/US11285170B2/en active Active
- 2018-05-22 AU AU2018272839A patent/AU2018272839B2/en active Active
- 2018-05-22 CA CA3064733A patent/CA3064733A1/en not_active Abandoned
- 2018-05-22 BR BR112019024628-2A patent/BR112019024628A2/pt not_active Application Discontinuation
- 2018-05-22 CN CN201880039992.5A patent/CN111093646A/zh active Pending
- 2018-05-22 IL IL270759A patent/IL270759B2/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022505234A5 (enExample) | ||
| JP2024528697A5 (enExample) | ||
| JP2016534153A5 (enExample) | ||
| JP2018168165A5 (enExample) | ||
| JP2020007350A5 (enExample) | ||
| CN104395391A (zh) | 双重衍生化的壳聚糖纳米粒子以及制造和使用其用于体内基因转移的方法 | |
| JP7373508B2 (ja) | エキノカンジン抗真菌剤の合成 | |
| JP2016505071A5 (enExample) | ||
| EP3474853A1 (en) | Liponucleotide-based therapy for ards | |
| JP2015519358A (ja) | スルフォラファンの単離及び精製 | |
| JP2022527401A5 (enExample) | ||
| CN115605194A (zh) | 过度炎症综合征的治疗 | |
| JP2025118775A5 (enExample) | ||
| US11286287B2 (en) | Antimicrobial and anti-cancer therapy | |
| CN101522195B (zh) | 含有苯基脒衍生物的药物组合物和该药物组合物与抗真菌剂的联合使用方法 | |
| KR20200143499A (ko) | S-아포모르핀의 결정형 | |
| JP2020019765A (ja) | 高濃縮アルファ−１プロテイナーゼインヒビターを含む組成物及びそれを得るための方法 | |
| JP2016517435A5 (ja) | メロペネム誘導体及びその製造法 | |
| RU2019139930A (ru) | Фракционированные антимикробные композиции и их применение | |
| JP2025514630A5 (enExample) | ||
| TWI694838B (zh) | 用於疏水性藥物傳送的新穎以聚合物爲基礎的增溶物 | |
| JP2023536119A5 (enExample) | ||
| JP6871919B2 (ja) | 薬物送達及びイメージング化学コンジュゲート、製剤及びその使用方法 | |
| JP2000512991A (ja) | 新規な形のｎ’ｎ―ジアセチルシスチン有機塩 | |
| CN117138057A (zh) | 一种水溶性恩诺沙星及其制备方法 |